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TO THE EDITOR
In a recent report, Dragulev et al.
(2006) tested the hypothesis that
stromal fibroblasts may participate in
the pathophysiology of Loxosceles
spider envenomation, which is charac-
terized by local skin injury as well as
systemic toxicity including severe
inflammation. To this end, the authors
determined the fibroblast gene expres-
sion response to sphingomyelinase D
(SMD), the causative agent of Loxos-
celes venom. They found that SMD
upregulates the expression of proin-
flammatory cytokines and chemokines,
such as IL-6, IL-8, CXCL1, and CXCL2.
On the basis of these results, the
authors hypothesized that ceramide-1-
phosphate (C1P), the product of sphin-
gomyelin (SM) hydrolysis in the outer
leaflet of the plasma membrane, is
responsible for the observed upregula-
tion of proinflammatory genes. How-
ever, although the conversion of SM
to C1P in the outer leaflet may mod-
ulate ion channel activity (Ramu
et al., 2006), C1P is not obviously a
signaling molecule. How then does
SMD trigger an inflammatory response
in its target cells?
What the authors do not mention is
the fact that SMD has intrinsic lysopho-
spholipase D activity to generate the
lipid mediator lysophosphatidic acid
(LPA) from lysophosphatidylcholine
(van Meeteren et al., 2004; Lee and
Lynch, 2005). Through activation of its
cognate G protein-coupled receptors,
LPA exerts numerous biological and
pathophysiological responses in many
different cell types (Moolenaar et al.,
2004). By producing bioactive LPA,
SMD can activate LPA receptor-
mediated signaling pathways that may
impinge on inflammatory gene expres-Abbreviations: SMD, sphingomyelinase D; LPA, lysophosphatidic acid; C1P, ceramide-1-phosphate
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sion; indeed, LPA induces the expression
of various cytokines, including IL-6, IL-8,
CXCL1, and CCL2 (e.g., Palmetshofer
et al., 1999; Fang et al., 2004; Klemm
et al., 2007; C. Stortelers, unpublished
results). That LPA is a key mediator of
SMD activity is demonstrated by the
failure of SMD to evoke biological effects
in LPA receptor-negative cells (van
Meeteren et al., 2004). Thus, LPA rather
than C1P is the likely trigger of the
observed inflammatory response to Lox-
osceles SMD. Specific LPA antagonists
could be useful tools for the treatment of
bites by Loxosceles spiders.
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TO THE EDITOR
We thank the authors for presenting
these valuable comments and for giving
us the opportunity to extend the dis-
cussion limited by the format of the
paper. van Meeteren et al. (2004)
confirmed that recombinant SMDs from
Loxosceles laeta and Corynebacterium
pseudotuberculosis possessed intrinsic
lysophospholipase D activity to gener-
ate bioactive lysophosphatidic acid.
They demonstrated that SMD did not
activate mitogen-activated protein ki-
nase (ERK1/2) in receptor-deficient
B103 neuroblastoma cells, whereas
both SMDs were activating mitogen-
activated protein kinase when the same
cells expressed lysophosphatidic acid1
receptors. They also showed that bac-
terial and Loxosceles SMDs triggered
receptor internalization in HEK293
cells only when preincubated with
albumin-LPC. Lee and Lynch (2005)
extended the findings by demonstrating
that recombinant L. reclusa SMD hy-
drolzses various lysophospholipids and
identified specific histidine residues
that are essential for the enzyme
activity.
Pettus et al. (2003, 2004) in two
consequential investigations provided
evidence that ceramide-1-phosphate
(C1P) interacts directly with cytosolic
phospholipase A2 (cPLA2) acting as an
activator of cPLA2 and subsequent
inflammatory response. They deter-
mined that in A549 lung adenocarci-
noma cells, natural and endogenous
(produced by SMD) C1Ps were potent
and specific inducers of arachidonic
acid and prostanoid synthesis. The
treatment of A549 cells with SMD
resulted in a threefold increase in
arachidonic acid release. Using RNA-
mediated interference technology, Pet-
tus et al. confirmed in A549 and in
J774.1 microphages that cPLA2 was
downstream of C1P. It was also found
that in A549 cells, C1P caused translo-
cation of cPLA2 to membranes. Their in
vitro binding studies disclosed that C1P
directly binds and activate with full-
length cPLA2. Other publications re-
garding biological activities of C1P are
reviewed in details by Gomez-Munoz
(2004).
The focus of our investigation was the
expression pattern of human fibroblasts
treated with recombinant SMD to gain
insight into cellular mechanisms of
loxoscelism pathology. We observed a
dose- and time-dependent upregulation
of several cytokines (data not shown).
The pattern of continuous increase was
present up to 18 hours of treatment (data
not shown). Although we recognize the
evidence that lysophospholipase D ac-
tivity of SMD is obviously an important
factor in loxoscelism, we are not con-
vinced that the sphingomyelin–ceramide
pathway involvement in the L. reclusa
pathology can be ignored. More than
one mechanism of action is also possible
in this pathology and further investiga-
tion would benefit the understanding of
the complex immunological response
following spider envenomation.
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